KRAS and familial pancreatic carcinoma: Through GESA, we noted that the high expression of PCSK6 was correlated with the up-regulation of the Kras signaling pathway compared to the low expression of PCSK6 in the cell lines of pancreatic cancer (Figure 8A,B).